Hepatitis C elimination among drug users in China: challenges, strategies and experiences.
10.3760/cma.j.cn501113-20210311-00116
- Author:
Tao WU
1
;
Feng LIN
1
;
Jiao WANG
1
;
Hui LI
1
;
Ming LIU
1
;
Yan Ru ZHANG
1
;
Wen Wei WANG
2
;
Fan HUANG
2
Author Information
1. Department of Infectious Diseases, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou 570105, China NHC Key Laboratory of Control of Tropical Diseases, Hainan Medical University, Haikou 570311, China.
2. Department of Infectious Diseases, Fujian Jianxin Hospital, Fuzhou 350002, China.
- Publication Type:Journal Article
- MeSH:
Humans;
Drug Users;
Hepatitis C/drug therapy*;
Hepacivirus;
China/epidemiology*;
Mass Screening;
Antiviral Agents/therapeutic use*
- From:
Chinese Journal of Hepatology
2022;30(9):1002-1006
- CountryChina
- Language:Chinese
-
Abstract:
The prevalence of hepatitis C among drug users in China is high, and thus it is one of the populations that needs attention to achieve hepatitis C elimination. However, due to the complexities of this population's situation, hepatitis C elimination still faces many challenges, such as difficult screening, low cure rate, poor compliance, and high reinfection rates. Therefore, the existing diagnostic and therapeutic system cannot meet the needs of this population. China has pledged to establish a unified system for drug users that will integrate drug treatment programs, education, medical care, and rehabilitation, creating favorable conditions for integrating hepatitis C diagnosis and treatment and improving the accessibility of drug users. Starting with the current situation and challenges of eliminating hepatitis C among drug users in China, in combination with cases from other countries, this paper discusses the strategy for eliminating hepatitis C and introduces what Hainan Province did to eliminate hepatitis C among drug users.
